Company Horizon Therapeutics Public Limited Company
Equities
HZNP
IE00BQPVQZ61
Pharmaceuticals
Business Summary
Number of employees: 2,190
Managers
Managers | Title | Age | Since |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 08-05-31 |
Aaron Cox
DFI | Director of Finance/CFO | 41 | 16-03-31 |
Karin Rosen
CTO | Chief Tech/Sci/R&D Officer | 57 | 20-11-01 |
Vikram Karnani
CTO | Chief Tech/Sci/R&D Officer | 49 | 14-06-30 |
Chief Tech/Sci/R&D Officer | 66 | 16-09-30 | |
Jeffrey Sherman
CTO | Chief Tech/Sci/R&D Officer | 69 | 09-05-31 |
Keli Walbert
SAM | Sales & Marketing | - | 17-12-31 |
Comptroller/Controller/Auditor | 45 | 15-01-31 | |
David Caraher
SEC | Corporate Secretary | - | - |
Jane Gonnerman
HRO | Human Resources Officer | - | 21-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 08-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 229,378,934 | 226,691,767 ( 98.83 %) | 384,366 ( 0.1676 %) | 98.83 % |
Company contact information
Horizon Therapeutics Plc
70 St. Stephen's Green
4, Dublin
+353 1 772 2100
http://www.horizontherapeutics.comGroup companies
Name | Category and Sector |
---|---|
Horizon Pharma Treasury Ltd.
|
Sector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |